Correction to: From understanding diseases to drug design: can artificial intelligence bridge the gap?

Full text

Vol.:(0123456789)
Artificial Intelligence Review (2024) 57:177
https://doi.org/10.1007/s10462-024-10765-8
1 3
PUBLISHER CORRECTION
Correction to: From understanding diseases todrug design:
can artificial intelligence bridge thegap?
AnjuChoorakottayilPushkaran1· AlyaA.Arabi1
© The Author(s) 2024
Correction to: Artifcial Intelligence Review (2024) 57:86
https://doi.org/10.1007/s10462-024-10714-5
The Publishing Team missed some corrections during the proofreading stage. Below is the
list of corrections:
Page 2 of 38: Fig.1 is shifted to the top of Page 2 of 38.
Page 2 of 38: The term “For example” was split between pages 2 and 4 with a Table1 in
between. The text is now shifted so that “For example” is together.
Page 2 of 38: A full stop is added at the end of the following statement: “Table1 provides a list of
some important summary tables and figures reported in the literature about AI in drug discovery.”.
Page 2 of 38: The statement “and below is a brief description of the most used classes and
subclasses of AI algorithms in this review” was deleted.
Page 2 of 38: The statement “There are different classes of ML methods, among which the
most commonly used methods…” is now replaced with “There are different classes of ML
methods. The most commonly used methods…”.
Page 5 of 38: Two commas are added in the following statement: “A major limitation of
DNNs is their complex nature, which makes them challenging to interpret, …”.
Page 7 of 38: Table2 is rotated.
Page 9 of 38: The hyphen in `AI-methods` is removed in the following statement: “At the
end of each section, we present a critical review on the AI methods discussed, …”
Page 11 of 38: The following sentence now begins on a new line: “AI has also significantly
assisted in the early detection of a life-threatening condition called sepsis, where the body
develops an extreme immune response towards infections.”
Page 18 of 38: A full stop is added at the end of the following statement: “Since many diseases
are associated with the upregulation or downregulation of certain proteins, it is important to
correctly identify the protein responsible for causing a disease during drug development.”
Page 28 of 38: A comma is replaced with a full stop at the end of the following statement:
“…, we propose establishing a comprehensive repository of protein structures with stand-
ardized data content and formats.”
The original article can be found online at https:// doi. org/ 10. 1007/ s10462- 024- 10714-5.
* Alya A. Arabi
alya.arabi@uaeu.ac.ae; alya.arabi@dal.ca
1 College ofMedicine andHealth Sciences, Department ofBiochemistry andMolecular Biology,
United Arab Emirates University, P. O. Box: 15551, AlAin, UnitedArabEmirates
Content courtesy of Springer Nature, terms of use apply. Rights reserved.

A.C.Pushkaran, A.A.Arabi
1 3
177 Page 2 of 2
Page 31 of 38: The following sentence now begins on a new line: “We foresee that the
future of AI-assisted drug discovery involves the development of a comprehensive virtual
human model that encompasses the intricate complexity of human beings.”
Page 33 of 38: A full stop is added at the end of the following reference: “DePristo M,
Poplin R (2017) DeepVariant: highly accurate genomes with deep neural networks. Google
AI Blog.”.
Page 34 of 38: A full stop is added at the end of the following reference: “K FM, Mohan M
(2022) Ensemble learning models for drug target interaction prediction. International Con-
ference on Applied Artificial Intelligence and Computing.”.
The original version has been corrected.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Com-
mons licence, and indicate if changes were made. The images or other third party material in this article
are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
Content courtesy of Springer Nature, terms of use apply. Rights reserved.

1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center
GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers
and authorised users (“Users”), for small-scale personal, non-commercial use provided that all
copyright, trade and service marks and other proprietary notices are maintained. By accessing,
sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of
use (“Terms”). For these purposes, Springer Nature considers academic use (by researchers and
students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and
conditions, a relevant site licence or a personal subscription. These Terms will prevail over any
conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription (to
the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of
the Creative Commons license used will apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may
also use these personal data internally within ResearchGate and Springer Nature and as agreed share
it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not otherwise
disclose your personal data outside the ResearchGate or the Springer Nature group of companies
unless we have your permission as detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial
use, it is important to note that Users may not:
use such content for the purpose of providing other users with access on a regular or large scale
basis or as a means to circumvent access control;
use such content where to do so would be considered a criminal or statutory offence in any
jurisdiction, or gives rise to civil liability, or is otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association
unless explicitly agreed to by Springer Nature in writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a
systematic database of Springer Nature journal content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a
product or service that creates revenue, royalties, rent or income from our content or its inclusion as
part of a paid for service or for other commercial gain. Springer Nature journal content cannot be
used for inter-library loans and librarians may not upload Springer Nature journal content on a large
scale into their, or any other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not
obligated to publish any information or content on this website and may remove it or features or
functionality at our sole discretion, at any time with or without notice. Springer Nature may revoke
this licence to you at any time and remove access to any copies of the Springer Nature journal content
which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or
guarantees to Users, either express or implied with respect to the Springer nature journal content and
all parties disclaim and waive any implied warranties or warranties imposed by law, including
merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published
by Springer Nature that may be licensed from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a
regular basis or in any other manner not expressly permitted by these Terms, please contact Springer
Nature at
onlineservice@springernature.com